Literature DB >> 31497171

Failure of drug-coated balloon angioplasty to treat bare metal in-stent restenosis accompanied by late stent thrombosis but successful treatment of binary in-stent restenosis.

Takuya Shimizu1,2, Jun-Ei Obata1, Ken Umetani2, Kiyotaka Kugiyama1.   

Abstract

Drug-coated balloons (DCB) are effective in treating in-stent restenosis (ISR) with neointimal proliferation after bare-metal stent (BMS) implantation, but it is unclear whether DCB are effective in treating BMS-ISR accompanied by thrombosis. An 84-year-old man with previous inferior myocardial infarction and atrial fibrillation developed acute myocardial infarction (AMI) during hospitalization for intracerebral hemorrhage. Emergent coronary angiography (CAG) revealed severe stenosis of the distal left circumflex coronary artery. We implanted a BMS to avoid long-term triple antithrombotic therapy. He received aspirin, clopidogrel, and rivaroxaban for 1 month and then received clopidogrel and rivaroxaban. Seventy days after BMS implantation, he developed AMI, and emergent CAG revealed occlusion of the BMS due to late stent thrombosis. After thrombus aspiration, intravascular ultrasound showed incomplete neointimal healing in the proximal portion of the stent and excessive neointimal proliferation in the distal portion of the stent. DCB angioplasty of the entire BMS was performed after scoring balloon pre-dilation. Seven months after BMS implantation, follow-up CAG revealed binary ISR. DCB angioplasty of the entire BMS was performed again after scoring balloon pre-dilation. Thirteen months after BMS implantation, follow-up CAG did not reveal recurrence of ISR. <Learning objective: Drug-coated balloons (DCB) were ineffective when there was excessive neointimal proliferation accompanied by thrombosis, but effective in binary in-stent restenosis (ISR). DCB may be ineffective in early ISR after bare-metal stent implantations and when there is excessive neointimal proliferation accompanied by thrombosis. Since the safety and efficacy of DCB to treat excessive neointimal proliferation occurring with late stent thrombosis is unclear, further studies are needed.>.

Entities:  

Keywords:  Bare-metal stent; Binary in-stent restenosis; Drug-coated balloon; Excessive neointimal proliferation; Late stent thrombosis

Year:  2019        PMID: 31497171      PMCID: PMC6718827          DOI: 10.1016/j.jccase.2019.04.007

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

Review 1.  Inflammation and restenosis in the stent era.

Authors:  Frederick G P Welt; Campbell Rogers
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-11-01       Impact factor: 8.311

2.  Longitudinal stent deformation as a cause of very late stent thrombosis: Optical coherence tomography images.

Authors:  Nobuaki Kobayashi; Noritake Hata; Hirotake Okazaki; Wataru Shimizu
Journal:  Int J Cardiol       Date:  2015-09-21       Impact factor: 4.164

3.  Drug-Coated Balloon Treatment of Very Late Stent Thrombosis Due to Complicated Neoatherosclerosis.

Authors:  Fernando Alfonso; Teresa Bastante; Javier Cuesta; Amparo Benedicto; Fernando Rivero
Journal:  Arq Bras Cardiol       Date:  2016-06       Impact factor: 2.000

4.  A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.

Authors:  Seiji Habara; Masashi Iwabuchi; Naoto Inoue; Shigeru Nakamura; Ryuta Asano; Shinsuke Nanto; Yasuhiko Hayashi; Nobuo Shiode; Shigeru Saito; Yuji Ikari; Takeshi Kimura; Joji Hosokawa; Masato Nakamura; Jun-ichi Kotani; Ken Kozuma; Kazuaki Mitsudo
Journal:  Am Heart J       Date:  2013-08-13       Impact factor: 4.749

5.  Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS).

Authors:  Gregory Y H Lip; Stephan Windecker; Kurt Huber; Paulus Kirchhof; Francisco Marin; Jurriën M Ten Berg; Karl Georg Haeusler; Giuseppe Boriani; Davide Capodanno; Martine Gilard; Uwe Zeymer; Deirdre Lane; Robert F Storey; Hector Bueno; Jean-Philippe Collet; Laurent Fauchier; Sigrun Halvorsen; Maddalena Lettino; Joao Morais; Christian Mueller; Tatjana S Potpara; Lars Hvilsted Rasmussen; Andrea Rubboli; Juan Tamargo; Marco Valgimigli; Jose L Zamorano
Journal:  Eur Heart J       Date:  2014-08-25       Impact factor: 29.983

6.  Local lesion-related factors and restenosis after coronary angioplasty. Evidence from a quantitative angiographic study in patients with unstable angina undergoing double-vessel angioplasty.

Authors:  P de Groote; C Bauters; E P McFadden; J M Lablanche; F Leroy; M E Bertrand
Journal:  Circulation       Date:  1995-02-15       Impact factor: 29.690

7.  First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes.

Authors:  Anouar Belkacemi; Pierfrancesco Agostoni; Hendrik M Nathoe; Michiel Voskuil; ChunLai Shao; Eric Van Belle; Thierry Wildbergh; Luigi Politi; Pieter A Doevendans; Giuseppe M Sangiorgi; Pieter R Stella
Journal:  J Am Coll Cardiol       Date:  2012-04-11       Impact factor: 24.094

8.  Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery.

Authors:  D I Axel; W Kunert; C Göggelmann; M Oberhoff; C Herdeg; A Küttner; D H Wild; B R Brehm; R Riessen; G Köveker; K R Karsch
Journal:  Circulation       Date:  1997-07-15       Impact factor: 29.690

9.  Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.

Authors:  Takeshi Tada; Kazushige Kadota; Shingo Hosogi; Koshi Miyake; Masanobu Ohya; Hideo Amano; Yu Izawa; Takenori Kanazawa; Shunsuke Kubo; Tahei Ichinohe; Yusuke Hyoudou; Yuki Hayakawa; Mahmoud Mohamed Hassan Sabbah; Suguru Otsuru; Daiji Hasegawa; Seiji Habara; Hiroyuki Tanaka; Yasushi Fuku; Harumi Katoh; Tsuyoshi Goto; Kazuaki Mitsudo
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-03-09       Impact factor: 6.875

10.  Pathological mechanisms of fatal late coronary stent thrombosis in humans.

Authors:  Andrew Farb; Allen P Burke; Frank D Kolodgie; Renu Virmani
Journal:  Circulation       Date:  2003-09-22       Impact factor: 29.690

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.